More Support for Genetic Testing of Hepatitis C Patients
A large retrospective study further confirms that the IL28B genotype predicts both early and sustained responses to interferon-based Hepatitis C treatment.
Continue reading »A large retrospective study further confirms that the IL28B genotype predicts both early and sustained responses to interferon-based Hepatitis C treatment.
Continue reading »In the debate over coffee's effect on health, coffee lovers who are undergoing treatment for Hepatitis C have just scored a victory.
Continue reading »A California based health system will be one of the first to routinely order IL28B genotyping on all patients with Hepatitis C who are potential candidates for antiviral therapy.
Continue reading »The disturbing health insurance gap in America leaves nearly two thirds of eligible Hepatitis C patients without access to treatment.
Continue reading »If chronic Hepatitis B or C has rendered you incapable of performing any work, Social Security disability benefits may provide a safety net. Understanding the guidelines for disability will help those truly in need to better work their way through an intensive application process.
Continue reading »A recent, popular television show educated viewers on the importance of raising glutathione levels. Although the practical suggestions given were accurate, there is much more to know about this topic. Especially important for Hepatitis C patients, two supplements demonstrate unparalleled glutathione-boosting power.
Continue reading »A United Kingdom charity is spearheading the development of a large network of patients and research to better understand, treat and prevent the Hepatitis C virus.
Continue reading »Most of us know that alcohol is not good for someone with the Hepatitis C virus. In addition to alcohol's ability to speed up the progress of liver disease, there is now proof that drinking during antiviral therapy nullifies the effectiveness of Hepatitis C treatment.
Continue reading »A genetic variant appears to protect against anemia brought on by Hepatitis C antiviral treatment.
Continue reading »Likely due to its ability to dramatically improve the Hepatitis C cure rate, Vertex's telaprevir will get a priority review by the FDA.
Continue reading »You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window